Hair Dye Cleared of Cancer Risk

Spanish researchers find no real connection

TUESDAY, May 24, 2005 (HealthDay News) -- The millions of people with faux hair color can breathe a sigh of relief: New research from Spain suggests that hair dye does not appear to increase the risk of cancer.

At the same time, the study authors caution that this may not the final word on the subject -- more research may be needed on a tiny link seen between hair dyes and cancers such as leukemia and multiple myeloma.

"Our study is just the best summary of current scientific knowledge on the topic," said study author Dr. Bahi Takkouche, a preventive medicine professor at the University of Santiago de Compostela. "One can never rule out that, in the future, several individual studies will find strong harmful effects. Still, the news is quite reassuring for hair dye users."

"The data should give reassurance to people that the risks of modern hair dye usage as a predisposition to cancer are, at most, very minimal," added Dr. Robert Morgan Jr., section head of medical gynecologic oncology at City of Hope Cancer Center in Duarte, Calif.

Previous epidemiological studies had suggested that hair dye might be a risk factor for several different types of cancer, including bladder cancer. Researchers had speculated that compounds called aromatic amines, which are contained in the dyes, might be responsible for the association.

According to the authors of the current study, about one third of women in Europe and North America color their hair, as do about 10 percent of men over the age of 40. The majority (about 70 percent) use permanent dyes.

For this paper, which appears in the May 25 issue of the Journal of the American Medical Association, the researchers analyzed data from 79 studies performed in 11 countries. Overall, they found no increased risk of breast and bladder cancer in people who used hair dye.

There was a small increased risk for blood cancers, but the association was a weak one.

"The borderline increase in the risk for hematopoietic cancers is not 'robust,' and may be easily explained by publication bias," Takkouche said. "Publication bias exists when there are studies that are not published, either because the editors reject them, or because the authors themselves fail to send them for publication. These studies are generally negative."

There were also small risk increases seen in brain and ovarian cancer, but this association is also suspect.

"The results concerning brain and ovarian cancers are based on minimal sample sizes (only two studies in each case), [so] they are not as reliable as the results of the rest of the cancers we studied," Takkouche said. "Besides, they are rare cancers, and the increase in the risk, even if it exists, would be of limited interest from the public health point of view."

"Epidemiologic studies are very difficult to perform and have previously implicated many potential sources of increased risks of these cancers without any definitive conclusions," Morgan added. "These studies are primarily hypothesis-generating and allow scientists to focus research on potential cancer-causing agents."

There was also a slightly increased risk of hematopoietic cancers in male users of hair dye. "This is an unexplained finding," Takkouche said. "We do not know whether the increase is real, or whether it is due to methodologic issues."

In addition to looking at male users of hair dye, Takkouche said that future research should be focused on the possible cancer-promoting effects of occupational exposure to hair dyes, such as that encountered by hair dressers and cosmetologists. Here, the exposure is higher and more prolonged than with personal use, Takkouche noted.

More information

The U.S. Food and Drug Administration has information on precautions to take when using hair dye.

Related Stories

No stories found.
logo
www.healthday.com